Crossmark

Treatment of hypertriglyceridaemia with icosapent ethyl in patients with high/very high cardiovascular risk. Consensus document of the Sociedad Española de Cardiología [Spanish Society of Cardiology] and the Sociedad Española de Diabetes [Spanish Diabetes Society]

Crossref DOI link: https://doi.org/10.1016/j.endien.2022.11.009

Published Print: 2023-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Pedro-Botet, Juan

Barrios, Vivencio

Sánchez-Margalet, Víctor

Tamargo, Juan

Arrieta, Francisco

Gámez, José Mª

Gimeno-Orna, José Antonio

Escobar, Carlos

Gómez-Doblas, Juan José

Pérez, Antonio
License Information

Text and Data Mining valid from 2023-03-01
More Information

This article is maintained by: Elsevier

Article Title: Treatment of hypertriglyceridaemia with icosapent ethyl in patients with high/very high cardiovascular risk. Consensus document of the Sociedad Española de Cardiología [Spanish Society of Cardiology] and the Sociedad Española de Diabetes [Spanish Diabetes Society]

Journal Title: Endocrinología, Diabetes y Nutrición (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.endien.2022.11.009

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.endinu.2022.03.004

Content Type: article

Copyright: © 2022 SEEN and SED. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below